FR2455890A1 - Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences - Google Patents

Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences

Info

Publication number
FR2455890A1
FR2455890A1 FR8010288A FR8010288A FR2455890A1 FR 2455890 A1 FR2455890 A1 FR 2455890A1 FR 8010288 A FR8010288 A FR 8010288A FR 8010288 A FR8010288 A FR 8010288A FR 2455890 A1 FR2455890 A1 FR 2455890A1
Authority
FR
France
Prior art keywords
tauroline
animals
derivatives
eliminate
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8010288A
Other languages
English (en)
Other versions
FR2455890B1 (fr
Inventor
Rolf Wilhelm Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of FR2455890A1 publication Critical patent/FR2455890A1/fr
Application granted granted Critical
Publication of FR2455890B1 publication Critical patent/FR2455890B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

SOLUTION AQUEUSE MEDICAMENTEUSE. ELLE COMPREND UN COMPOSE DE FORMULE I : (CF DESSIN DANS BOPI) DANS LAQUELLE R EST UN ATOME D'HYDROGENE OU UN GROUPE ALCOYLE AYANT DE 1 A 6 ATOMES DE CARBONE ET R EST UN ATOME D'HYDROGENE, UN GROUPE ALCOYLE AYANT DE 1 A 6 ATOMES DE CARBONE OU UN GROUPE DE FORMULEII: (CF DESSIN DANS BOPI) DANS LAQUELLE R EST TEL QUE DEFINI CI-DESSUS. PREVIENT LES ADHERENCES SE FORMANT NOTAMMENT EN CAS D'INTERVENTIONS CHIRURGICALES.
FR8010288A 1979-05-09 1980-05-08 Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences Expired FR2455890B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7916017 1979-05-09

Publications (2)

Publication Number Publication Date
FR2455890A1 true FR2455890A1 (fr) 1980-12-05
FR2455890B1 FR2455890B1 (fr) 1987-01-23

Family

ID=10505028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8010288A Expired FR2455890B1 (fr) 1979-05-09 1980-05-08 Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences

Country Status (9)

Country Link
US (1) US4337251A (fr)
JP (1) JPS55151513A (fr)
AU (1) AU519407B2 (fr)
BE (1) BE883151A (fr)
CA (1) CA1156146A (fr)
DE (1) DE3017711A1 (fr)
FR (1) FR2455890B1 (fr)
GB (1) GB2052257A (fr)
IT (1) IT1133005B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
DE3533612A1 (de) * 1985-09-20 1987-04-02 Johannes Reinmueller Neuartige verwendung von taurolin
IN166447B (fr) * 1985-11-27 1990-05-12 Ethicon Inc
US6011030A (en) * 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP5027369B2 (ja) * 1999-12-06 2012-09-19 ガイストリッヒ ファーマ アーゲー 腫瘍を治療する方法
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US6641571B2 (en) * 2000-01-05 2003-11-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
EP1450814B1 (fr) 2001-10-01 2016-11-30 Geistlich Pharma AG Procede d'inhibition de metastases
US20050008684A1 (en) * 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
CA2482687C (fr) * 2003-09-29 2012-11-20 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Traitement du mesotheliome
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
AU2011326519A1 (en) 2010-11-09 2013-05-30 Hans-Dietrich Polaschegg Hemodialysis access system
EP3727393A4 (fr) 2017-12-21 2021-10-06 CorMedix Inc. Procédés et compositions pharmaceutiques pour traiter candida auris dans le sang
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
FR2320101A1 (fr) * 1975-08-04 1977-03-04 Geistlich Soehne Ag Solutions a action antibacterienne amelioree a base de derives de thiadiazine
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
FR2320101A1 (fr) * 1975-08-04 1977-03-04 Geistlich Soehne Ag Solutions a action antibacterienne amelioree a base de derives de thiadiazine
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia

Also Published As

Publication number Publication date
IT1133005B (it) 1986-07-09
GB2052257A (en) 1981-01-28
JPS55151513A (en) 1980-11-26
BE883151A (fr) 1980-09-01
IT8048616A0 (it) 1980-05-08
AU519407B2 (en) 1981-12-03
US4337251A (en) 1982-06-29
DE3017711A1 (de) 1980-11-20
CA1156146A (fr) 1983-11-01
AU5816180A (en) 1980-11-13
FR2455890B1 (fr) 1987-01-23

Similar Documents

Publication Publication Date Title
FR2455890A1 (fr) Solution aqueuse de tauroline ou de derives de celle-ci destinee a etre utilisee pour le traitement de corps humains ou animaux afin d'eliminer ou d'eviter des adherences
AU2860889A (en) Aromatic esters and thioesters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions
TNSN92008A1 (fr) Steroides-esters nouveaux
JPS6429308A (en) Treatment of hyperhydrosis, psoriasis and wrinkle
ES2078509T3 (es) Composiciones inhibidoras de la reaccion de maillard.
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
CA2020923A1 (fr) Derives d'urethanne, leur preparation et leur application notamment comme agents hydratants dans des compositions cosmetiques ou pharmaceutiques destinees au traitement des peaux seches
IL62894A (en) Dibenzoxazepine derivatives,process for preparing the same and pharmaceutical compositions comprising the same
TNSN89016A1 (fr) Procede pour la preparation d'esters d'acide cepheme - carboxylique
FR2411843A1 (fr) Nouvelles 6-deoxyneamines eventuellement 1-n-alkylees et intermediaires necessaires a leur preparation
PT83309A (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
FR2409987A1 (fr) Nouveaux composes de sulfonanilide, leur procede de preparation et leur utilisation en agriculture
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
FR2358893A1 (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
TNSN99114A1 (fr) Oxo-thia-azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses
NO167865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 14,17beta-ethano-14beta-oestratrienderivater.
ATE1066T1 (de) Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
FR2424912A1 (fr) Derives de l'imidazole utilisables notamment pour le traitement de l'hypertension
NO910033L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters
ATE965T1 (de) Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
KR910011820A (ko) Ltb4 합성 저해제
FR2506312A1 (fr) Nouveaux derives de la quinidine, procede de preparation et application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse